Skip to main content
Image coming soon

Anti-Vedolizumab (Entyvio®)

$1,110.00
SKU:
TM09032
Bulk Pricing:
Buy in bulk and save
Adding to cart… The item has been added

ImmunoGuide® Enzyme immunoassay (ELISA) for the semi-quantitative determination of free antibodies to Vedolizumab (Entyvio®) in serum and plasma.<br><br>

The drug Vedolizumab (trade name Entyvio®) is a humanized immunoglobulin G1 monoclonal antibody that binds exclusively to the lymphocyte integrin α4β7, is indicated for the treatment of moderately to severely active ulcerative colitis [UC] or Crohn’s disease [CD]. During treatment the presence of persistent anti-Vedolizumab antibody was observed to substantially reduce serum concentrations of Vedolizumab, either to undetectable or negligible levels.<br><br>

The ImmunoGuide Antibody to Vedolizumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. For research use only, not for use in diagnostic procedures.

Assay Description:
1 hour incubation (RT) + 1 hour (RT) + 15 min. (RT) = 2 hour, 15 min. total incubation time
Catalog number:
TM09032
configuration:
96 Determinations, 12x8 removable strips
controls:
Positive control
design:
Enzyme immunoassay (ELISA) technique
FDA Status:
For research use only, not for use in diagnostic procedures
MSDS:
Available upon request
notes:
The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
Other names:
Entyvio®
Protocol:

Protocol

Sample types:
Serum and plasma
Sample volume:
10 µL
Standard range:
0 / 5 - 150 ng/mL
storage:
2 - 8 °C
sensitivity:
5 ng/mL
Species:
Human
Additional info:

Pamphlet